ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0739

Contextual Factors Should Complete the Assessment of Functioning in Patients with Axial Spondyloarthritis (axSpA)

Uta Kiltz1, Eerik Ahomaa2, Björn Buehring1, Xenofon Baraliakos1, David Kiefer1, Jaclyn-Dalisay Leicht1 and Jürgen Braun1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2St. Franziskus-Hospital, Department of Orthopedic Surgery, Cologne, Germany

Meeting: ACR Convergence 2021

Keywords: axial spondyloarthritis, Environmental factors, Outcome measures, Patient reported outcomes, physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Measurements (0739–0763)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Functioning of axSpA patients (pat.) is influenced by many factors, but how contextual factors influence functioning isn’t well studied. According to the International Classification of Functioning, Disability and Health (ICF), functioning is a complex interaction between health status and contextual factors such as social support, relationships and attitudes. Resulting from impaired functioning, pat. reporting barriers might face definite limitations in participation. Thus, limitations in participation as well as barriers and facilitators of contextual factors need to be investigated in axSpA pat.

Methods: axSpA pat. were standardized assessed, thereby collecting pat. and disease characteristics, patient-reported outcomes (ASDAS, BASFI, BASMI, PHQ-9, ICF Measure of Participation and ACTivities questionnaire (IMPACT-S (0-100%)), ASAS Health Index (ASAS HI and environment factor item set (EFIS) (1). The EFIS contains 9 dichotomous questions addressing ICF categories of products and technologies (e1), support and relationship (e3), attitudes (e4) and health services (e5). Prior to the analysis, EFIS 1, 4 and 8 were assumed to act as facilitators. Validated cut-offs of ASAS HI were used to categorize global functioning: good ≤ 5, moderate < 5 to < 12, poor ≥ 12.

Results: A total of 200 axSpA pat. were included: 69% males, 44.3±12.5 years, symptom duration 17.9±12.6 years, ASDAS 2.5±1.1, BASFI 4.0±2.7, BASMI 3.5±1.8, ASAS HI 7.0±4.1. Pat. reported limitations in the IMPACT-S activity and participation domain (82.3% (15.2) and 83.5% (16.8)), respectively. The majority of pat. reported that treatment of axSpA requires time (e4, 58.5%) as a barrier. Some pat. reported needs such as (a) the support by family members (e3, 43.5%), (b) to modify home and work environment (e1, 39.5%) and (c) the inreliability of family members for help (e3, 22%) as barriers. Some pat. (< 20%) reported (a) comprehension problems with health care professionals when experiencing a flare (e5, 18.5%), (b) inadequate care of pat. at home (e4, 18.5%), (c) disliking friends' behavior toward them (e4, 13.5%), and (d) too demanding friends (e4, 13%) as barriers. The majority of pat. (e4, 75.9%) identified attitudes of friends as the only and major facilitator. All pat. reporting at least one barrier, had significantly worse global functioning (ASAS HI, IMPACT-S), and depression (PHQ-9) compared to pat. reporting no barriers in the respective ICF categories (p< 0.01). Similarly, pat. with poor functioning are more likely to report barriers in contextual factors compared to pat. with good functioning (Table 1). Pat., who have to ask for more support from their families, expressed the feeling that they cannot rely on that.

Conclusion: Barriers of contextual factors are more present in axSpA pat. than facilitators. This study shows that barriers of contextual factors are more common in pat. with impairments in self-reported and performed functioning as in those without impairments, underlining the importance of contextual factors in the management of axSpA pat. The controversial response to EF-Items 1, 4 and 8 suggests relevant differences in the individual interpretation of these questions.

Table title (on top of table): Table 1: Presence of contextual factors, stratified for global functioning categories

Table legend (below table): values given as number (%), Reference: 1 Kiltz et al. Ann Rheum Dis 2013;72(s3):572


Disclosures: U. Kiltz, AbbVie, 2, 5, 6, Biocad, 2, 6, Eli Lilly, 2, 6, Grünenthal, 2, 6, Janssen, 2, 6, MSD, 2, 6, Amgen, 5, Biogen, 5, Fresenius, 5, GlaxoSmithKline, 5, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, Roche, 2, 6, UCB, 2, 6, Hexal, 2, 5, Chugai, 2, 5; E. Ahomaa, None; B. Buehring, None; X. Baraliakos, AbbVie, 2, 5, 6, Chugai, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6, Bristol-Myers Squibb, 2, 5, 6, Celegene, 2, 5, 6, Merck, 2, 6, Werfen, 2; D. Kiefer, None; J. Leicht, None; J. Braun, Abbvie, 2, 5, 6, Amgen, 2, 5, 6, Celltrion, 2, 5, 6, Chugai, 2, 5, 6, Medac, 2, 5, 6, MSD, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, Roche, 2, 5, 6, UCB, 2, 5, 6, BMS, 2, 5, 6, Boehringer, 2, 5, 6, Celgene, 2, 5, 6, Centocor, 2, 5, 6, Mundipharma, 2, 5, 6, Sanofi-Aventis, 2, 5, 6, Eli Lilly, 2, 5, 6, EBEWE Pharma, 2, 6.

To cite this abstract in AMA style:

Kiltz U, Ahomaa E, Buehring B, Baraliakos X, Kiefer D, Leicht J, Braun J. Contextual Factors Should Complete the Assessment of Functioning in Patients with Axial Spondyloarthritis (axSpA) [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/contextual-factors-should-complete-the-assessment-of-functioning-in-patients-with-axial-spondyloarthritis-axspa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contextual-factors-should-complete-the-assessment-of-functioning-in-patients-with-axial-spondyloarthritis-axspa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology